APA (7th ed.) Citation

Erol, C., Basoglu, T., Sakin, A., Ozden, E., Cubuk, D., Yumuk, P., . . . Sendur, M. (2021). 1405P Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group. Annals of Oncology, 32, S1058. https://doi.org/10.1016/j.annonc.2021.08.1514

Chicago Style (17th ed.) Citation

Erol, C., et al. "1405P Efficacy and Safety of Perioperative FLOT (5-FU, LV, Oxaliplatin, Docetaxel) Chemotherapy in Gastric and Gastroesophageal Junction Adenocarcinoma: Real-life Data from Turkish Oncology Group." Annals of Oncology 32 (2021): S1058. https://doi.org/10.1016/j.annonc.2021.08.1514.

MLA (9th ed.) Citation

Erol, C., et al. "1405P Efficacy and Safety of Perioperative FLOT (5-FU, LV, Oxaliplatin, Docetaxel) Chemotherapy in Gastric and Gastroesophageal Junction Adenocarcinoma: Real-life Data from Turkish Oncology Group." Annals of Oncology, vol. 32, 2021, p. S1058, https://doi.org/10.1016/j.annonc.2021.08.1514.